Cargando…
Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
Chronic migraine (CM) prevalence ranges around 1–5%. Most of these patients usually treat their acute attacks with triptans, whose efficacy is extremely variable. A genetic basis for migraine is evident and many susceptibility genes have been described, as well as gene polymorphisms possibly implied...
Autores principales: | Gentile, Giovanna, Missori, Serena, Borro, Marina, Sebastianelli, Alisa, Simmaco, Maurizio, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452288/ https://www.ncbi.nlm.nih.gov/pubmed/20213484 http://dx.doi.org/10.1007/s10194-010-0202-7 |
Ejemplares similares
-
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010) -
Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019) -
Tumor necrosis factor B gene polymorphism contributes to susceptibility to migraine without area
por: Martelletti, Paolo, et al.
Publicado: (2000) -
The omics in migraine
por: Lionetto, Luana, et al.
Publicado: (2013) -
Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015)